{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:56:14Z","timestamp":1793386574973,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82160446"],"award-info":[{"award-number":["82160446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10495-026-02362-7","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T16:58:43Z","timestamp":1779641923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Artesunate overcomes oxaliplatin resistance in colorectal cancer by inducing ferroptosis through inhibition of the CDK5\/Nrf2\/GPX4 pathway"],"prefix":"10.1007","volume":"31","author":[{"given":"Feng","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-huan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-tang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-zhi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ye","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-fang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang-li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,24]]},"reference":[{"issue":"3","key":"2362_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/pharmaceutics14030504","volume":"14","author":"N Ruwizhi","year":"2022","unstructured":"Ruwizhi N, Maseko RB, Aderibigbe BA (2022) Recent advances in the therapeutic efficacy of Artesunate. Pharmaceutics 14(3):504","journal-title":"Pharmaceutics"},{"key":"2362_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2026.109755","volume":"174","author":"M Ren","year":"2026","unstructured":"Ren M, Jian Z, Li C, Cao J, Ma X, He L, Zhang Y, Chen Y, Xu Y (2026) Design, synthesis, and in vitro\/in vivo biological evaluation of Artesunate-Ebselen derivatives: GPX4-targeted ferroptosis induction and synergistic antitumor immune activation in Colorectal Cancer. Bioorg Chem 174:109755","journal-title":"Bioorg Chem"},{"issue":"6","key":"2362_CR3","doi-asserted-by":"publisher","first-page":"e570","DOI":"10.1002\/mco2.570","volume":"5","author":"R Fan","year":"2024","unstructured":"Fan R, Deng A, Lin R, Zhang S, Cheng C, Zhuang J, Hai Y, Zhao M, Yang L, Wei G (2024) A platinum(IV)-artesunate complex triggers ferroptosis by boosting cytoplasmic and mitochondrial lipid peroxidation to enhance tumor immunotherapy. MedComm (2020) 5(6):e570","journal-title":"MedComm (2020)"},{"key":"2362_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111108","volume":"117","author":"Y Xia","year":"2024","unstructured":"Xia Y, Tang Y, Huang Z, Ke N, Zheng Y, Zhuang W, Zhang Y, Yin X, Tu M, Chen J et al (2024) Artesunate-loaded solid lipid nanoparticles resist esophageal Squamous Cell Carcinoma by inducing ferroptosis through inhibiting the AKT\/mTOR signaling. Cell Signal 117:111108","journal-title":"Cell Signal"},{"key":"2362_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ejpb.2023.07.014","volume":"190","author":"QF Huang","year":"2023","unstructured":"Huang QF, Li YH, Huang ZJ, Jun M, Wang W, Chen XL, Wang GH (2023) Artesunate carriers induced ferroptosis to overcome biological barriers for anti-cancer. Eur J Pharm Biopharm 190:284\u2013293","journal-title":"Eur J Pharm Biopharm"},{"issue":"8","key":"2362_CR6","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1142\/S0192415X25500922","volume":"53","author":"J Li","year":"2025","unstructured":"Li J, Zheng J, Cui Y, Liu Y, Fan H, Wang X, Liu H, Li X, Yu G, Luo Z (2025) The role of Artesunate in cancer management: mechanisms of biomedical effects and toxicology. Am J Chin Med 53(8):2489\u20132512","journal-title":"Am J Chin Med"},{"key":"2362_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.789284","volume":"12","author":"O Vakhrusheva","year":"2022","unstructured":"Vakhrusheva O, Erb HHH, Braunig V, Markowitsch SD, Schupp P, Baer PC, Slade KS, Thomas A, Tsaur I, Puhr M et al (2022) Artesunate inhibits the growth behavior of Docetaxel-resistant Prostate Cancer cells. Front Oncol 12:789284","journal-title":"Front Oncol"},{"issue":"12","key":"2362_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122643","volume":"9","author":"F Zhao","year":"2020","unstructured":"Zhao F, Vakhrusheva O, Markowitsch SD, Slade KS, Tsaur I, Cinatl J Jr., Michaelis M, Efferth T, Haferkamp A, Juengel E (2020) Artesunate impairs growth in Cisplatin-resistant Bladder Cancer cells by cell cycle arrest, apoptosis and autophagy induction. Cells 9(12):2643","journal-title":"Cells"},{"key":"2362_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"JL Roh","year":"2017","unstructured":"Roh JL, Kim EH, Jang H, Shin D (2017) Nrf2 inhibition reverses the resistance of Cisplatin-resistant Head and Neck Cancer cells to Artesunate-induced ferroptosis. Redox Biol 11:254\u2013262","journal-title":"Redox Biol"},{"key":"2362_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.biopha.2017.01.086","volume":"88","author":"M Ilamathi","year":"2017","unstructured":"Ilamathi M, Sivaramakrishnan V (2017) Artesunate acts as fuel to fire in sensitizing HepG2 cells towards TRAIL mediated apoptosis via STAT3 inhibition and DR4 augmentation. Biomed Pharmacother 88:515\u2013520","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"2362_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1080\/15548627.2023.2261758","volume":"20","author":"Z Ma","year":"2024","unstructured":"Ma Z, Chen W, Liu Y, Yu L, Mao X, Guo X, Jiang F, Guo Q, Lin N, Zhang Y (2024) Artesunate sensitizes human Hepatocellular Carcinoma to Sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy. Autophagy 20(3):541\u2013556","journal-title":"Autophagy"},{"key":"2362_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121608","volume":"287","author":"M Ismail","year":"2022","unstructured":"Ismail M, Yang W, Li Y, Chai T, Zhang D, Du Q, Muhammad P, Hanif S, Zheng M, Shi B (2022) Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma. Biomaterials 287:121608","journal-title":"Biomaterials"},{"key":"2362_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402795","author":"Y Di","year":"2024","unstructured":"Di Y, Zhang X, Wen X, Qin J, Ye L, Wang Y, Song M, Wang Z, He W (2024) MAPK signaling-mediated RFNG phosphorylation and nuclear translocation restrain oxaliplatin-induced apoptosis and ferroptosis. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202402795","journal-title":"Adv Sci"},{"issue":"7","key":"2362_CR14","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1016\/j.apsb.2024.02.024","volume":"14","author":"J Li","year":"2024","unstructured":"Li J, Zhang Q, Yang H, Lu W, Fu Y, Xiong Y, Wang X, Lu T, Xin Y, Xie Z et al (2024) Sequential dual-locking strategy using photoactivated Pt(IV)-based metallo-nano prodrug for enhanced chemotherapy and photodynamic efficacy by triggering ferroptosis and macrophage polarization. Acta Pharm Sin B 14(7):3251\u20133265","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"2362_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12035-025-05300-x","volume":"63","author":"H Lv","year":"2025","unstructured":"Lv H, Mao N, Liu A, Zhao X, Zhu B (2025) Puerarin alleviates high-fat high-sugar diet-induced Alzheimer\u2019s disease-like pathology and insulin resistance in mice by inhibiting p35\/CDK5-mediated mitochondrial fission. Mol Neurobiol 63(1):9","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2362_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s11658-025-00822-7","volume":"30","author":"Y Li","year":"2025","unstructured":"Li Y, Li H, Chen X, Li X, Su J, Yang S, Xiao W, Deng Z (2025) CDK5 regulates PPARgamma\/NF-kappaB signaling to exacerbate obesity-related osteoarthritis via modulating macrophage polarization and chondrocyte apoptosis. Cell Mol Biol Lett 30(1):135","journal-title":"Cell Mol Biol Lett"},{"issue":"10","key":"2362_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.333","volume":"7","author":"K Zhuang","year":"2016","unstructured":"Zhuang K, Zhang J, Xiong M, Wang X, Luo X, Han L, Meng Y, Zhang Y, Liao W, Liu S (2016) CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. Cell Death Dis 7(10):e2415","journal-title":"Cell Death Dis"},{"issue":"1","key":"2362_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/1535-7163.MCT-08-0659","volume":"8","author":"A Martinez-Cardus","year":"2009","unstructured":"Martinez-Cardus A, Martinez-Balibrea E, Bandres E, Malumbres R, Gines A, Manzano JL, Taron M, Garcia-Foncillas J, Abad A (2009) Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer. Mol Cancer Ther 8(1):194\u2013202","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"2362_CR19","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1080\/21655979.2021.1995994","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Wu B, Zhong B, Lin L, Ding Y, Jin X, Huang Z, Lin M, Wu H, Xu D (2021) Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) \/system xc-\/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 12(2):10924\u201310934","journal-title":"Bioengineered"},{"key":"2362_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2022.122289","volume":"291","author":"W Jia","year":"2023","unstructured":"Jia W, Jin X, Liu W, Zhao B, Zhang M, Yang Y, Yin W, Zhang Y, Liu Y, Zhou S et al (2023) Evaluation the binding of chlorogenic acid with bovine serum albumin: spectroscopic methods, electrochemical and molecular docking. Spectrochim Acta A Mol Biomol Spectrosc 291:122289","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"11","key":"2362_CR21","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1038\/s41596-024-01011-0","volume":"19","author":"RV Honorato","year":"2024","unstructured":"Honorato RV, Trellet ME, Jimenez-Garcia B, Schaarschmidt JJ, Giulini M, Reys V, Koukos PI, Rodrigues J, Karaca E, van Zundert GCP et al (2024) The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat Protoc 19(11):3219\u20133241","journal-title":"Nat Protoc"},{"issue":"11","key":"2362_CR22","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/cdd.2015.49","volume":"22","author":"D Jimenez-Blasco","year":"2015","unstructured":"Jimenez-Blasco D, Santofimia-Castano P, Gonzalez A, Almeida A, Bolanos JP (2015) Astrocyte NMDA receptors\u2019 activity sustains neuronal survival through a Cdk5-Nrf2 pathway. Cell Death Differ 22(11):1877\u20131889","journal-title":"Cell Death Differ"},{"key":"2362_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439191","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Zhang M, Zhang X, Zhou Y, Ma T, Liang J, Zhang J (2024) Glioblastoma-derived exosomes promote lipid accumulation and induce ferroptosis in dendritic cells via the NRF2\/GPX4 pathway. Front Immunol 15:1439191","journal-title":"Front Immunol"},{"issue":"11","key":"2362_CR24","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1002\/ptr.8310","volume":"38","author":"X Zheng","year":"2024","unstructured":"Zheng X, Ye FC, Sun T, Liu FJ, Wu MJ, Zheng WH, Wu LF (2024) Delay the progression of glucocorticoid-induced osteoporosis: Fraxin targets ferroptosis via the Nrf2\/GPX4 pathway. Phytother Res 38(11):5203\u20135224","journal-title":"Phytother Res"},{"issue":"1","key":"2362_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1142\/S0192415X24500071","volume":"52","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yuan X, Ren M, Wang Z (2024) Ferroptosis: a new research direction of artemisinin and its derivatives in anti-cancer treatment. Am J Chin Med 52(1):161\u2013181","journal-title":"Am J Chin Med"},{"issue":"6","key":"2362_CR26","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201867R","volume":"37","author":"J Liu","year":"2023","unstructured":"Liu J, Pan Z, Tong B, Wang C, Yang J, Zou J, Jiang J, Zhang L, Jiang B (2023) Artesunate protects against ocular fibrosis by suppressing fibroblast activation and inducing mitochondria-dependent ferroptosis. FASEB J 37(6):e22954","journal-title":"FASEB J"},{"key":"2362_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107733","volume":"152","author":"M Ren","year":"2024","unstructured":"Ren M, Liang S, Lin S, Huang R, Chen Y, Zhang Y, Xu Y (2024) Design, synthesis and biological evaluation of artesunate-Se derivatives as anticancer agents by inducing GPX4-mediated ferroptosis. Bioorg Chem 152:107733","journal-title":"Bioorg Chem"},{"issue":"8","key":"2362_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1093\/hmg\/ddac293","volume":"32","author":"C Zhao","year":"2023","unstructured":"Zhao C, Zhao L, Zhou Y, Feng Y, Li N, Wang K (2023) Artesunate ameliorates osteoarthritis cartilage damage by updating MTA1 expression and promoting the transcriptional activation of LXA4 to suppress the JAK2\/STAT3 signaling pathway. Hum Mol Genet 32(8):1324\u20131333","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2362_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41419-022-04810-z","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Wang Y, Yin C, Gong P, Zhang Z, Zhao L, Waxman S, Jing Y (2022) Artesunate improves venetoclax plus cytarabine AML cell targeting by regulating the Noxa\/Bim\/Mcl-1\/p-Chk1 axis. Cell Death Dis 13(4):379","journal-title":"Cell Death Dis"},{"issue":"6","key":"2362_CR30","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1086\/591195","volume":"47","author":"T Efferth","year":"2008","unstructured":"Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M (2008) The antiviral activities of artemisinin and artesunate. Clin Infect Dis 47(6):804\u2013811","journal-title":"Clin Infect Dis"},{"key":"2362_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth T (2017) From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 46:65\u201383","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"2362_CR32","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/med.21580","volume":"39","author":"X Sun","year":"2019","unstructured":"Sun X, Yan P, Zou C, Wong YK, Shu Y, Lee YM, Zhang C, Yang ND, Wang J, Zhang J (2019) Targeting autophagy enhances the anticancer effect of artemisinin and its derivatives. Med Res Rev 39(6):2172\u20132193","journal-title":"Med Res Rev"},{"issue":"1","key":"2362_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/jcb.27456","volume":"120","author":"YS Lee","year":"2019","unstructured":"Lee YS, Lee DH, Jeong SY, Park SH, Oh SC, Park YS, Yu J, Choudry HA, Bartlett DL, Lee YJ (2019) Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5. J Cell Biochem 120(1):928\u2013939","journal-title":"J Cell Biochem"},{"issue":"10","key":"2362_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s12032-023-02130-6","volume":"40","author":"M Golbashirzadeh","year":"2023","unstructured":"Golbashirzadeh M, Heidari HR, Aghamolayi AA, Fattahi Y, Talebi M, Khosroushahi AY (2023) In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis. Med Oncol 40(10):279","journal-title":"Med Oncol"},{"issue":"1","key":"2362_CR35","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12951-023-01998-w","volume":"21","author":"Z Rao","year":"2023","unstructured":"Rao Z, Xia Y, Jia Q, Zhu Y, Wang L, Liu G, Liu X, Yang P, Ning P, Zhang R et al (2023) Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination. J Nanobiotechnology 21(1):265","journal-title":"J Nanobiotechnology"},{"issue":"6","key":"2362_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167210","volume":"1870","author":"H Jiang","year":"2024","unstructured":"Jiang H, Zeng Y, Jiang X, Xu X, Zhao L, Yuan X, Xu J, Zhao M, Wu F, Li G (2024) Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer. Biochim Biophys Acta Mol Basis Dis 1870(6):167210","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Pt A","key":"2362_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113041","volume":"142","author":"M Zhu","year":"2024","unstructured":"Zhu M, Yu J (2024) Salidroside alleviates ferroptosis in FAC-induced Age-related macular degeneration models by activating Nrf2\/SLC7A11\/GPX4 axis. Int Immunopharmacol 142(Pt A):113041","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2362_CR38","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s11427-023-2589-1","volume":"68","author":"C Xiong","year":"2024","unstructured":"Xiong C, Ling H, Huang Y, Dong H, Xie B, Hao Q, Zhou X (2024) AZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis. Sci China Life Sci 68(1):204\u2013218","journal-title":"Sci China Life Sci"},{"issue":"1","key":"2362_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-025-00414-1","volume":"14","author":"Q Wu","year":"2025","unstructured":"Wu Q, Zhu X, Wan X, Lu X, Chen J, Ying Z, Li Y, Hu X, Lu J, Lou Y et al (2025) Cdk5 regulates glutamine metabolism in colorectal cancer via the EZH2-GLS1 axis. Cancer Metab 14(1):1","journal-title":"Cancer Metab"},{"issue":"1","key":"2362_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/jnen\/nlaf092","volume":"85","author":"N Liu","year":"2026","unstructured":"Liu N, Peng A, Peng B, Xia H, Zhang Z, Zhang D, Xu S, Xu H (2026) Downregulating Cdk5 reverses hippocampal neuron ferroptosis by regulating the AMP-activated protein kinase pathway and \u201cM1\u201d polarized microglia. J Neuropathol Exp Neurol 85(1):71\u201383","journal-title":"J Neuropathol Exp Neurol"},{"key":"2362_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.116129","volume":"171","author":"M Huang","year":"2026","unstructured":"Huang M, Liu X, Tang B, Tang X, Ai X (2026) circSERINC3 facilitates STAT3-CDK5 crosstalk to orchestrate immunosuppressive microenvironments in pancreatic cancer. Int Immunopharmacol 171:116129","journal-title":"Int Immunopharmacol"},{"issue":"7679","key":"2362_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ, Bole D, Eaton JK, Matov A, Galeas J, Dhruv HD, Berens ME, Schreiber SL et al (2017) Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551(7679):247\u2013250","journal-title":"Nature"},{"issue":"1","key":"2362_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48307-z","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Li Q, Chen X, Weng M, Huang Y, Chen Q, Liu X, Huang H, Feng Y, Zhou H et al (2024) Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. Nat Commun 15(1):4296","journal-title":"Nat Commun"},{"key":"2362_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101052","volume":"73","author":"SH Hao","year":"2024","unstructured":"Hao SH, Ma XD, Xu L, Xie JD, Feng ZH, Chen JW, Chen RX, Wang FW, Tang YH, Xie D et al (2024) Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma. Drug Resist Updat 73:101052","journal-title":"Drug Resist Updat"},{"issue":"2","key":"2362_CR45","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41401-024-01378-6","volume":"46","author":"PX Deng","year":"2024","unstructured":"Deng PX, Silva M, Yang N, Wang Q, Meng X, Ye KQ, Gao HC, Zheng WH (2024) Artemisinin inhibits neuronal ferroptosis in Alzheimer\u2019s disease models by targeting KEAP1. Acta Pharmacol Sin 46(2):326\u2013337","journal-title":"Acta Pharmacol Sin"},{"key":"2362_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103342","volume":"76","author":"J Liu","year":"2024","unstructured":"Liu J, Pang SY, Zhou SY, He QY, Zhao RY, Qu Y, Yang Y, Guo ZN (2024) Lipocalin-2 aggravates blood-brain barrier dysfunction after intravenous thrombolysis by promoting endothelial cell ferroptosis via regulating the HMGB1\/Nrf2\/HO-1 pathway. Redox Biol 76:103342","journal-title":"Redox Biol"},{"issue":"1","key":"2362_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41401-024-01367-9","volume":"46","author":"L Wu","year":"2024","unstructured":"Wu L, Wang LT, Du YX, Zhang YM, Ren J (2024) Asiatic acid ameliorates doxorubicin-induced cardiotoxicity by promoting FPN-mediated iron export and inhibiting ferroptosis. Acta Pharmacol Sin 46(1):81\u201395","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"2362_CR48","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02362-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10495-026-02362-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-026-02362-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:14:55Z","timestamp":1782850495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10495-026-02362-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,24]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1007\/s10495-026-02362-7","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,24]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approval by the Ethics Committee of Guangxi Medical University Cancer Hospital (DW 2024-KY-GJ-043). The animal experimental procedures in mice were approved by the ethics committee of Animal Experiments of Guangxi Medical University (DW 2024-KY-GJ-042). All the procedures were carried out in accordance with institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}}],"article-number":"156"}}